The Yerevan Pathway was adopted when the UN's biodiversity summit closed on 31 October, not on 5 November. The newer date belongs to a post-summit analysis of what negotiators left unresolved: how to stop public money from damaging nature, how promised funding reaches conservation work, and how communities share in commercial benefits derived from genetic information. The test of the agreement is beginning only now.

A pathway agreed in October, not a new deal in November

The UN Biodiversity Conference in Yerevan, Armenia, closed on 31 October after negotiations ran beyond the scheduled 30 October finish. Governments adopted the Yerevan Pathway as their collective response to a first review of progress under the Kunming-Montreal Global Biodiversity Framework. The framework, agreed in 2022, sets 23 targets for 2030. The Yerevan agreement asks countries to accelerate implementation, improve monitoring and put biodiversity into choices about public spending. It does not mean the 2030 goals have already been achieved.

A Reuters Ethical Corporation analysis published on 5 November revisited the summit and examined the disagreements that remain, especially over subsidies and the sharing of benefits from genetic information. That article was a post-conference assessment, not an announcement that the Pathway had been adopted again on 5 November. Its assessments and interviews illuminate contested policy choices; the CBD's closing account and conference material establish when the decisions were made.

Sources: COP 17 / CP-MOP-12 / NP-MOP-06 — conference overview and High-Level Segment outcomes · UN Biodiversity Conference charts Yerevan Pathway to accelerate global action for nature · Biodiversity summit saw progress on subsidy reform, but pharma firms push back against fund for Indigenous peoples · COP17: Key outcomes agreed at the UN biodiversity conference in Yerevan

Why the first global review changed the conversation

The CBD's State of Biodiversity Action report assessed information from national reports, biodiversity strategies and other evidence. Its conclusion was uncomfortable: current action is not on course to deliver the full set of 23 global targets by 2030. That finding helps explain why the Yerevan Pathway emphasizes implementation rather than announcing an entirely new set of goals. Agreeing a target is a political act; changing land-use policies, monitoring ecological outcomes and allocating staff and money are much harder processes.

The review also has limitations. Countries have unequal monitoring capacity, and missing measurements do not always prove that conservation work has not occurred. Conversely, a submitted national plan is not evidence that forests, rivers or species have recovered. The meaningful test now is whether governments change their budgets and incentives, make their progress measurable and publish information that can be checked before the next global review.

Sources: UN Biodiversity Conference charts Yerevan Pathway to accelerate global action for nature · State of Biodiversity Action: The Global Report on collective progress · COP17: Key outcomes agreed at the UN biodiversity conference in Yerevan

The subsidy problem sits inside national budgets

Target 18 of the global biodiversity framework calls for governments to identify incentives harmful to biodiversity and reduce them by at least $500 billion a year by 2030, while expanding incentives that protect nature. Support for agriculture, fisheries and other sectors can serve legitimate social or economic aims, yet some forms of support can also encourage resource depletion or habitat destruction. The policy question is not simply whether to remove every subsidy. It is how to identify its environmental effects and redesign it without transferring disproportionate costs to vulnerable households or producers.

COP17 placed greater emphasis on accelerating this work, but a negotiating priority is not a completed national reform. Reuters described businesses and investors urging a change of direction while recognizing that implementing it will require continued pressure. The CBD's Target 18 guidance itself calls for a proportionate, fair approach that considers people who depend on existing support. Future national budgets, tax measures and subsidy inventories—not conference speeches—will reveal whether those principles lead to changed incentives.

Sources: UN Biodiversity Conference charts Yerevan Pathway to accelerate global action for nature · Kunming-Montreal Global Biodiversity Framework — Target 18 · Biodiversity summit saw progress on subsidy reform, but pharma firms push back against fund for Indigenous peoples · COP17: Key outcomes agreed at the UN biodiversity conference in Yerevan

Nearly $2 billion was pledged, not paid out

The CBD Secretariat reported nearly $2 billion in new biodiversity-related funding announcements around COP17. Its closing account mentioned $560 million associated with GEF-9 replenishment and the Global Biodiversity Framework Fund, $500 million through the Species Recovery Alliance and more than $330 million through the Value Nature Fund. The conference page separately recorded $1.8 billion in pledges by the end of the 27–28 October high-level segment. Those are announcements at different reporting points, not amounts to add together as if they were independent pots of cash.

A pledge is an intention or commitment; it is not proof that an amount has been transferred to a fund, disbursed to a project or spent in a community. Some initiatives also seek to mobilize private investment, whose eventual scale and timing are uncertain. The framework's Target 19 aims to mobilize at least $200 billion a year from all sources by 2030, a recurring global target that should not be confused with the much smaller one-off COP17 announcements. Independent scrutiny needs to follow committed amounts through contracts, transfers, spending and verifiable results.

Sources: COP 17 / CP-MOP-12 / NP-MOP-06 — conference overview and High-Level Segment outcomes · UN Biodiversity Conference charts Yerevan Pathway to accelerate global action for nature · Kunming-Montreal Global Biodiversity Framework — 2030 Targets (including Target 19) · Biodiversity summit saw progress on subsidy reform, but pharma firms push back against fund for Indigenous peoples · COP17: Key outcomes agreed at the UN biodiversity conference in Yerevan

Digital genetic information raises a different fairness test

Digital sequence information, often shortened to DSI, is genetic information derived from organisms and used in research and commercial development. As sequences can be stored and reused in databases, benefit-sharing cannot be addressed only through rules for transporting physical samples. The Cali Fund was created through the CBD process to receive contributions associated with commercial use of DSI. The CBD says half its resources are intended for the self-identified needs of Indigenous peoples and local communities, whose stewardship is central to the agreement's fairness goals.

Yet creating a fund and raising usable revenue are different achievements. Reuters' 5 November analysis reported that the Cali Fund had attracted only about $10,000 and described objections from the pharmaceutical industry to its design, alongside criticism from Indigenous representatives who want clear rules and direct benefits. The industry argued the mechanism could overlap with existing law and fail to reflect how medicines are developed. Those positions are attributed arguments, not settled findings. The practical dispute is how contributions are calculated, who participates, and how communities can see and control the benefits intended for them.

Sources: The Cali Fund launches in the margins of the resumed session of COP16 · Biodiversity summit saw progress on subsidy reform, but pharma firms push back against fund for Indigenous peoples · COP17: Key outcomes agreed at the UN biodiversity conference in Yerevan

Representation improved; delivery remains the test

COP17 also agreed rules of operation for a permanent subsidiary body on Article 8(j), the treaty provision concerning Indigenous peoples and local communities. The CBD described the Sevan Guidelines as an important step in enabling participation in biodiversity governance. That institutional change matters because communities should not be treated merely as beneficiaries of decisions taken elsewhere. But having a permanent place in negotiations is not the same as enforceable land rights, a functioning payments channel or predictable access to resources.

The next test will be whether national governments publish and act on subsidy-reform plans, whether biodiversity pledges become traceable financial flows, whether the Cali Fund attracts contributions and supports community-defined priorities, and whether ecological indicators improve. COP18 is scheduled for Ecuador in 2028, giving governments a checkpoint before the 2030 deadline. The Yerevan Pathway has supplied a political route map; the evidence of progress will come from implementation, not from another declaration of ambition.

Sources: COP 17 / CP-MOP-12 / NP-MOP-06 — conference overview and High-Level Segment outcomes · UN Biodiversity Conference charts Yerevan Pathway to accelerate global action for nature · The Cali Fund launches in the margins of the resumed session of COP16 · Biodiversity summit saw progress on subsidy reform, but pharma firms push back against fund for Indigenous peoples · COP17: Key outcomes agreed at the UN biodiversity conference in Yerevan · 17th UN Biodiversity Conference wraps up: an honest assessment — but still a steep climb ahead